Tayebi Pouya, Zavareh Mahmoud Sadeghi Haddad, Tayyebi Gooya, Abdollahi Fatemeh Zahra, Mahmoudlou Fatemeh
Department of Vascular and Endovascular Surgery, Rouhani Hospital, Babol, Iran.
Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Vasc Specialist Int. 2021 Nov 22;37:36. doi: 10.5758/vsi.210039.
Acute thromboembolic events have been frequently reported in patients with coronavirus disease 2019 (COVID-19) due to an increase in the coagulation system activity and endothelial dysfunction. This report describes a patient with COVID-19 who initially reported respiratory symptoms and developed acute lower limb ischemia secondary to extensive macrovascular arterial thrombosis, which was treated with thrombectomy. The development of such extensive arterial thrombosis with anticoagulants at therapeutic doses is a new sign of increased viral pathogenicity, and it is necessary to develop and apply updated prophylaxis protocols for thrombosis in these patients.
由于凝血系统活性增加和内皮功能障碍,急性血栓栓塞事件在2019冠状病毒病(COVID-19)患者中经常被报道。本报告描述了一名COVID-19患者,该患者最初报告有呼吸道症状,随后因广泛的大血管动脉血栓形成而发展为急性下肢缺血,并接受了血栓切除术治疗。在使用治疗剂量抗凝剂的情况下出现如此广泛的动脉血栓形成是病毒致病性增加的一个新迹象,因此有必要制定和应用针对这些患者的最新血栓预防方案。